PharmaShots | Incisive News in 3 Shots

Subscribe Now

DLBCL

Genentech Reports Results of Polivy (polatuzumab vedotin-piiq) + R-CHP in P-III POLARIX Trial for the Treatment of Diffuse Large B-Cell Lymphoma

Genentech Reports Results of Polivy (polatuzumab vedotin-piiq) + R-CHP in P-III POLARIX Trial for the Treatment of Diffuse Large B...

August 9, 2021

Roche's Polatuzumab Vedotin as Combination Therapy & Entrectinib Receives FDA's Priority Review for r/r Diffuse DLBCL & NTRK Fusion-Positive Solid Tumors

Roche's Polatuzumab Vedotin as Combination Therapy & Entrectinib Receives FDA's Priority Review for r/r Diffuse DLBCL & NT...

February 19, 2019

Novartis' Kymriah Receives NICE Approval for R/R Diffuse Large B-cell lymphoma (DLBCL) in Adults

Novartis' Kymriah Receives NICE Approval for R/R Diffuse Large B-cell lymphoma (DLBCL) in Adults

February 4, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us